Literature DB >> 8057439

The human astrovirus RNA-dependent RNA polymerase coding region is expressed by ribosomal frameshifting.

B Marczinke1, A J Bloys, T D Brown, M M Willcocks, M J Carter, I Brierley.   

Abstract

The genomic RNA of human astrovirus serotype 1 (HAst-1) contains three open reading frames (ORFs), 1a, 1b, and 2. ORF 1b is located downstream of, and overlaps, 1a, and it has been suggested on the basis of sequence analysis that expression of ORF 1b is mediated through -1 ribosomal frameshifting. To examine this possibility, a cDNA fragment containing the 1a-1b overlap region was cloned within a reporter gene and placed under the control of the bacteriophage SP6 promoter in a recombinant plasmid. Synthetic transcripts derived from this plasmid, when translated in the rabbit reticulocyte lysate cell-free system, specified the synthesis of polypeptides whose size and antibody reactivity were consistent with an efficient -1 ribosomal frameshift event at the overlap region. The HAst-1 frameshift signal has two essential components, a heptanucleotide slippery sequence, A6C, and a stem-loop structure in the RNA. The presence of this structure was confirmed by complementary and compensatory mutation analysis and by direct structure probing with single- and double-stranded RNA-specific reagents. The HAst-1 frameshift signal, like that present at the overlap of the gag and pro genes of the retrovirus human T-cell lymphotrophic virus type II, does not involve the formation of an RNA pseudoknot.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8057439      PMCID: PMC236959          DOI: 10.1128/JVI.68.9.5588-5595.1994

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  Expression of the Rous sarcoma virus pol gene by ribosomal frameshifting.

Authors:  T Jacks; H E Varmus
Journal:  Science       Date:  1985-12-13       Impact factor: 47.728

2.  RNA sequence of astrovirus: distinctive genomic organization and a putative retrovirus-like ribosomal frameshifting signal that directs the viral replicase synthesis.

Authors:  B Jiang; S S Monroe; E V Koonin; S E Stine; R I Glass
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-15       Impact factor: 11.205

3.  Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter.

Authors:  D A Melton; P A Krieg; M R Rebagliati; T Maniatis; K Zinn; M R Green
Journal:  Nucleic Acids Res       Date:  1984-09-25       Impact factor: 16.971

4.  Rapid and efficient site-specific mutagenesis without phenotypic selection.

Authors:  T A Kunkel
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

5.  Functional analysis of bacteriophage f1 intergenic region.

Authors:  G P Dotto; V Enea; N D Zinder
Journal:  Virology       Date:  1981-10-30       Impact factor: 3.616

6.  An improved filamentous helper phage for generating single-stranded plasmid DNA.

Authors:  M Russel; S Kidd; M R Kelley
Journal:  Gene       Date:  1986       Impact factor: 3.688

7.  Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors.

Authors:  C Yanisch-Perron; J Vieira; J Messing
Journal:  Gene       Date:  1985       Impact factor: 3.688

8.  Analysis of astrovirus serotype 1 RNA, identification of the viral RNA-dependent RNA polymerase motif, and expression of a viral structural protein.

Authors:  T L Lewis; H B Greenberg; J E Herrmann; L S Smith; S M Matsui
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  Primary structural comparison of RNA-dependent polymerases from plant, animal and bacterial viruses.

Authors:  G Kamer; P Argos
Journal:  Nucleic Acids Res       Date:  1984-09-25       Impact factor: 16.971

View more
  39 in total

1.  Molecular characterization of an avian astrovirus.

Authors:  M D Koci; B S Seal; S Schultz-Cherry
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

2.  Kinetics of ribosomal pausing during programmed -1 translational frameshifting.

Authors:  J D Lopinski; J D Dinman; J A Bruenn
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

3.  Processing of nonstructural protein 1a of human astrovirus.

Authors:  Ute Geigenmüller; Teri Chew; Nancy Ginzton; Suzanne M Matsui
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

4.  Structural analysis of the -1 ribosomal frameshift elements in giardiavirus mRNA.

Authors:  L Li; A L Wang; C C Wang
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

5.  Proteolytic processing of a serotype 8 human astrovirus ORF2 polyprotein.

Authors:  Ernesto Méndez; Teresa Fernández-Luna; Susana López; Martha Méndez-Toss; Carlos F Arias
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

6.  Protein products of the open reading frames encoding nonstructural proteins of human astrovirus serotype 8.

Authors:  Ernesto Méndez; M P Elizabeth Salas-Ocampo; María Elena Munguía; Carlos F Arias
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

Review 7.  Identification of structural domains involved in astrovirus capsid biology.

Authors:  Neel K Krishna
Journal:  Viral Immunol       Date:  2005       Impact factor: 2.257

Review 8.  Programmed translational frameshifting.

Authors:  P J Farabaugh
Journal:  Microbiol Rev       Date:  1996-03

9.  Determination of the full length sequence of a chicken astrovirus suggests a different replication mechanism.

Authors:  Kyung-il Kang; Alan H Icard; Erich Linnemann; Holly S Sellers; Egbert Mundt
Journal:  Virus Genes       Date:  2011-08-31       Impact factor: 2.332

10.  Astrovirus ribosomal frameshifting in an infection-transfection transient expression system.

Authors:  T L Lewis; S M Matsui
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.